Boston Scientific(US:BSX) ZACKSยท2025-07-08 23:16Company Performance - Boston Scientific (BSX) closed at $102.41, reflecting a -1.37% change from the previous day, underperforming the S&P 500 which lost 0.07% [1] - Over the last month, BSX shares increased by 3.79%, outperforming the Medical sector's loss of 1.3% but lagging behind the S&P 500's gain of 3.94% [1] Upcoming Earnings - The earnings report for Boston Scientific is scheduled for July 23, 2025, with projected EPS of $0.72, indicating a 16.13% increase year-over-year [2] - Revenue is expected to reach $4.89 billion, representing an 18.69% growth compared to the same quarter last year [2] Full Year Projections - Zacks Consensus Estimates forecast earnings of $2.91 per share and revenue of $19.5 billion for the full year, reflecting increases of +15.94% and +16.42% respectively from the prior year [3] - Recent changes to analyst estimates are seen as positive indicators for the business outlook [3] Valuation Metrics - Boston Scientific has a Forward P/E ratio of 35.62, significantly higher than the industry average of 19.12, indicating a premium valuation [6] - The company's PEG ratio stands at 2.7, compared to the industry average PEG ratio of 2.26 [6] Industry Context - The Medical - Products industry, part of the Medical sector, holds a Zacks Industry Rank of 89, placing it in the top 37% of over 250 industries [7] - Historically, the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]